News About: Pharm. Industry
Local pharmaceutical industry undergoes transition
The local pharmaceutical industry is undergoing a major transformation as tightening regulations and uphill competition combine to reshuffle the leader board of drug manufacturers.
So far, Dong-A Pharmaceutical has...
Establishment of drug distribution cooperatives eyed
The committee for the projected drug distribution cooperatives of small- and medium-sized pharmaceutical wholesalers has unveiled its plan to establish the cooperatives in collaboration with local or foreign enterpris...
Geoyoung to go on IPO
Geoyoung Group, the largest domestic pharmaceutical wholesaler, said it plans to file an initial public offering (IPO) to list its shares on the tech-loaded Kosdaq market in the second half of next year.
To this en...
Government urged to boost local pharmaceutical industry
In recent years, uncertainty has tended to increase in Korea’s pharmaceutical industry as a result of the government’s campaign to lower drug prices.
To lower drug prices, the government has implemented a series of...
Sanofi Aventis Korea unchanges company name
Sanofi Aventis Korea decided to maintain its company name while using the changed logo of Sanofi.
By contrast, French based Sanofi-Aventis shareholders approved a proposal by the board on May 7 to simplify the Fre...
Pharmaceutical firms are keen on reclassification of drugs
As a number of prescription drugs, including an anti-ulcerant Zantac and a contraceptive Norlevo, are likely be reclassified into over-the-counter (OTC) drugs, some pharmaceutical firms are said to seek to expand phar...
OTC sales at supermarket will hurt pharmaceutical sector
Korea's pharmaceutical sector could lose up to 200 billion won if 48 over-the-counter (OTC) drugs are available at supermarkets and 24-hour convenience stores nationwide from August, according to market watchers.
T...
Green Cross, Chong Kun Dang show brisk sales in second quarter
Green Cross Corp. became the third-biggest drug manufacturer in Korea in terms of quarterly revenue, while Chong Kung Dang Pharmaceutical is expected to see its sales further rise in the second quarter, High Investmen...
Diabetic patients are angry over reduced health coverage
Since the health insurance coverage for sustained release metformin, the first-line product for diabetes, is reduced from July 1, diabetic patients have vehemently protested against their increased medication costs at...
Novartis Korea releases Diovan 320 mg
Novartis Korea said it has recently launched Diovan 320 mg tablets here, which may be typically used as a final dosage for adults with high blood pressure. Of the four strength of Diovan (valsartan) on the market, the...
